Klotho Neurosciences Inc

Here is the public summary page for Klotho Neurosciences Inc. Please login to see the complete information for Klotho Neurosciences Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Klotho Neurosciences Inc stacks up relative to its peers.

Darwin Score	+26
Ticker	KLTO
Latest Price	0.96 USD as of close on 31-Jul-2025
3 Month price range	0.13 to 2.01 USD
Market Capitalisation	17.65Mn USD
Country	United States of America
Region	North America
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates comprise KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska. See More ...
Company URL	https://klothoneuro.com

See Darwins Full Analysis for Klotho Neurosciences Inc

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Klotho Neurosciences Inc. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+18
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	0
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	+8

Peer Comparison

There is 1 peer of Klotho Neurosciences Inc.
Asset Name Industry Group Perf(20d)% Asset Score
Sagimet Biosciences Inc (SGMT) Biotechnology +7.2 +27